一般外科
主治項目或專長
甲狀腺及副甲狀腺手術（含無痕經口達文西機器手臂手術）
甲狀腺微創射頻消融手術
乳房腫瘤手術及乳癌治療（含微創內視鏡手術）
腹部外傷與急症
論文研究
1. Kuo CY, Hsu YC, Chen MJ, Lin CH, Li YS, Cheng SP. Glucose Transporter 1 Inhibitors Induce Autophagy and Synergize With Lenvatinib in Thyroid Cancer Cells. Head Neck. 2025 Feb;47(2):615-624.
2. Kuo CY, Chien MN, Lee JJ, Dai SH, Cheng SP. Can we diagnose noninvasive follicular thyroid neoplasm with papillary-like nuclear features before surgery? Updates Surg. 2025 Jan 15.
3. Chi SY, Kuo CY, Cheng SP. Temporal research trends in parathyroid surgery. Am J Surg. 2024 Nov;237:115941.
4. Kuo CY, Tsai CH, Lee JJ, Cheng SP. Abnormalities of serum magnesium levels in dialysis patients undergoing parathyroidectomy. Updates Surg. 2024 Aug;76(4):1435-1441.
5. Kuo CY, Tsai CH, Wu JK, Cheng SP. Sublethal thermal stress promotes migration and invasion of thyroid cancer cells. PLoS ONE. 2024 Feb 23;19(2): e0298903.
6. Kuo CY, Hsu YC, Liu CL, Li YS, Chang SC, Cheng SP. SOX4 is a pivotal regulator of tumorigenesis in differentiated thyroid cancer. Molecular and Cellular Endocrinology 2023;578:112062.
7. Tsai CH, Kuo CY, Leu YS, Lee JJ, Cheng SP. Impact of completion thyroidectomy on postoperative recovery in patients with differentiated thyroid cancer. Updates in Surgery 2023;75:209-216.
8. Liu CL, Hsu YC, Kuo CY, Jhuang JY, Li YS, Cheng SP. CRABP2 is associated with thyroid cancer recurrence and promotes invasion via the integrin/FAK/AKT pathway. Endocrinology 2022;163:bqac171.
9. Kuo CY, Jhuang JY, Huang WC, Cheng SP. Aberrant expression of thymosin beta-4 correlates with advanced disease and BRAF V600E mutation in thyroid cancer. Journal of Histochemistry & Cytochemistry 2022;70:707-716.
10. Huang SS, Tsai CH, Kuo CY, Li YS, Cheng SP. ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells. Endocrine 2022;78:85-94.
11. Lee F, Kuo CY, Tsai CH, Cheng SP. Propensity score-matched analysis to identify pathways associated with loss of sodium iodide symporter in papillary thyroid cancer. Current Issues in Molecular Biology 2022;44:1488-1496.
12. Kuo CY, Chang YC, Chien MN, Jhuang JY, Hsu YC, Huang SY, Cheng SP. SREBP1 promotes invasive phenotypes by upregulating CYR61/CTGF via the Hippo-YAP pathway. Endocrine-Related Cancer 2022;29:47-58.
13. Kuo CY, Wu MH, Ko WC, Cheng SP. Computer-analyzed ultrasound predictors of the treatment efficacy of radiofrequency ablation for benign thyroid nodules. World Journal of Surgery 2022;46:112-120.
14. Lin WC, Wang CK, Wang WH, Kuo CY, Chiang PL, Lin AN, Baek JH, Wu MH, Cheng KL. Multicenter study of benign thyroid nodules with radiofrequency ablation: results of 762 cases over 4 years in Taiwan. Journal of Personalized Medicine 2022;12:63.
15. Kuo CY, Liu CL, Tsai CH, Cheng SP. Learning curve analysis of radiofrequency ablation for benign thyroid nodules. International Journal of Hyperthermia 2021;38:1536-1540.
16. Lai HF, Kuo CY, Cheng SP. Significance of telomerase reverse-transcriptase promoter mutations in differentiated thyroid cancer. Formosan Journal of Surgery 2021;54:171-176.
17. Cheng SP, Lee JJ, Chien MN, Kuo CY, Jhuang JY, Liu CL. Lymphovascular invasion of papillary thyroid carcinoma revisited in the era of active surveillance. European Journal of Surgical Oncology 2020;46:1814-1819.
18. Kuo CY, Yang PS, Chien MN, Cheng SP. Preoperative factors associated with extrathyroidal extension in papillary thyroid cancer. European Thyroid Journal 2020;9:256-262.
19. Tsai CH, Yang PS, Lee JJ, Liu TP, Kuo CY, Cheng SP. Effects of preoperative iodine administration on thyroidectomy for hyperthyroidism: a systematic review and meta-analysis. Otolaryngology-Head and Neck Surgery 2019;160:993-1002.
20. Kuo CY, Liu TP, Yang PS, Cheng SP. Characteristics of lymphocyte-infiltrating papillary thyroid cancer. Journal of Cancer Research and Practice 2017;4:95-99.